Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ACCENDRA HEALTH INC/VA/ACH · Entity 6858 | EVP, Chief Operating Officer | May 15, 2026 | May 19, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ACCENDRA HEALTH INC/VA/
Report date May 15, 2026 · Filed May 19, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 313,913 |
Reported balance
After 2026-05-15 transaction · row 1
1 source rowRow 1 · 2026-05-15 · Tax withholding · Disposed 7,908 · Balance 313,913 F1: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 15, 2026 Filed May 19, 2026 12:54 UTC | ACCENDRA HEALTH INC/VA/ ACH · Entity 6858 | Tax withholdingCommon Stock | 7,908 | $3.04 | $24,040.32 |
DisclosureSEC source: 0000075252-26-000033 · form4.xml · nonDerivative · entry 1 Bernocchi Perry A · CIK 0001967402 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 313,913 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| March 20, 2026 Filed Mar 24, 2026 21:40 UTC | ACCENDRA HEALTH INC/VA/ ACH · Entity 6858 | Tax withholdingCommon Stock | 20,841 | $2.03 | $42,307.23 |
DisclosureSEC source: 0000075252-26-000014 · form4.xml · nonDerivative · entry 1 Bernocchi Perry A · CIK 0001967402 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 321,821 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 01:02 UTC | ACCENDRA HEALTH INC/VA/ ACH · Entity 6858 | GrantCommon Stock | 108,696 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-26-000008 · form4.xml · nonDerivative · entry 1 Bernocchi Perry A · CIK 0001967402 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 342,662 F1 · security: Restricted stock grant which vests one-third per year over three years. Read SEC document |
| May 15, 2025 Filed May 16, 2025 20:07 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 13,394 | $7.00 | $93,758.00 |
DisclosureSEC source: 0001062993-25-009645 · form4.xml · nonDerivative · entry 1 Bernocchi Perry A · CIK 0001967402 · EVP, CEO,. Patient Direct 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 233,966 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| March 20, 2025 Filed Mar 24, 2025 23:42 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 5,551 | $10.09 | $56,009.59 |
DisclosureSEC source: 0001062993-25-006167 · form4.xml · nonDerivative · entry 1 Bernocchi Perry A · CIK 0001967402 · EVP, CEO,. Patient Direct 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 247,360 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 21:24 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 123,391 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-004560 · form4.xml · nonDerivative · entry 1 Bernocchi Perry A · CIK 0001967402 · EVP, CEO,. Patient Direct 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 252,911 F1 · security: Restricted stock grant which vests one-third per year over three years. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 20:49 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 2,833 | $17.48 | $49,526.22 |
DisclosureSEC source: 0001062993-24-012194 · form4.xml · nonDerivative · entry 4 Bernocchi Perry A · CIK 0001967402 · EVP, CEO,. Patient Direct 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 129,520 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 4, 2024. F5 · price: Weighted average of the sale price range of $17.30 - $17.75 Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 20:49 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 4,542 | $17.49 | $79,420.05 |
DisclosureSEC source: 0001062993-24-012194 · form4.xml · nonDerivative · entry 3 Bernocchi Perry A · CIK 0001967402 · EVP, CEO,. Patient Direct 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 132,353 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 4, 2024. F4 · price: Weighted average of the sale price range of $17.30 - $17.77 Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 20:49 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 10,756 | $17.49 | $188,136.42 |
DisclosureSEC source: 0001062993-24-012194 · form4.xml · nonDerivative · entry 2 Bernocchi Perry A · CIK 0001967402 · EVP, CEO,. Patient Direct 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 136,895 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 4, 2024. F3 · price: Weighted average of the sale price range of $17.285 - $17.78 Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 20:49 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 1,884 | $17.47 | $32,919.89 |
DisclosureSEC source: 0001062993-24-012194 · form4.xml · nonDerivative · entry 1 Bernocchi Perry A · CIK 0001967402 · EVP, CEO,. Patient Direct 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 147,651 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 4, 2024. F2 · price: Weighted average of the sale price range of $17.30 - $17.76 Read SEC document |
| May 15, 2024 Filed May 16, 2024 20:59 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 20,962 | $19.78 | $414,628.36 |
DisclosureSEC source: 0001062993-24-010494 · form4.xml · nonDerivative · entry 1 Bernocchi Perry A · CIK 0001967402 · EVP, CEO,. Patient Direct 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,535 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| May 01, 2024 Filed May 3, 2024 20:03 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 20,204 | $24.27 | $490,258.14 |
DisclosureSEC source: 0001062993-24-009327 · form4.xml · nonDerivative · entry 2 Bernocchi Perry A · CIK 0001967402 · EVP, CEO,. Patient Direct 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 170,497 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective August 11, 2023. F2 · price: Weighted average of the sale price range of $23.870 - $24.800 Read SEC document |
| May 01, 2024 Filed May 3, 2024 20:03 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 3,890 | $24.53 | $95,421.70 |
DisclosureSEC source: 0001062993-24-009327 · form4.xml · nonDerivative · entry 1 Bernocchi Perry A · CIK 0001967402 · EVP, CEO,. Patient Direct 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 190,701 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective August 11, 2023. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 01:39 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 14,946 | $24.99 | $373,500.54 |
DisclosureSEC source: 0001062993-24-006699 · form4.xml · nonDerivative · entry 1 Bernocchi Perry A · CIK 0001967402 · EVP, CEO,. Patient Direct 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 194,591 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:48 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 44,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-005529 · form4.xml · nonDerivative · entry 1 Bernocchi Perry A · CIK 0001967402 · EVP, CEO,. Patient Direct 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 209,537 F1 · security: Restricted stock grant which vests one-third per year over three years. Read SEC document |
| December 29, 2023 Filed Jan 18, 2024 13:52 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 547 | $16.18 | $8,852.65 |
DisclosureSEC source: 0001062993-24-000995 · form4.xml · nonDerivative · entry 1 Bernocchi Perry A · CIK 0001967402 · EVP, CEO,. Patient Direct 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,894 F1 · kind: Shares acquired under the Owens & Minor Teammate Stock Purchase Plan in a transaction that was exempt under Rule 16b-3(c). Read SEC document |
| November 22, 2023 Filed Nov 23, 2023 02:50 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 19,302 | $18.75 | $361,916.36 |
DisclosureSEC source: 0001062993-23-021402 · form4.xml · nonDerivative · entry 1 Bernocchi Perry A · CIK 0001967402 · EVP, CEO,. Patient Direct 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,347 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective August 11, 2023. F2 · price: Weighted average of the sale price range of $18.61 - $19.38. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 22:40 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 554 | $16.24 | $8,994.19 |
DisclosureSEC source: 0001062993-23-014518 · form4.xml · nonDerivative · entry 1 Bernocchi Perry A · CIK 0001967402 · EVP, CEO,. Patient Direct 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 183,649 F1 · kind: Shares acquired under the Owens & Minor Teammate Stock Purchase Plan in a transaction that was exempt under Rule 16b-3(c). Read SEC document |
| May 15, 2023 Filed May 17, 2023 20:03 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 6,998 | $18.73 | $131,072.54 |
DisclosureSEC source: 0001062993-23-011350 · form4.xml · nonDerivative · entry 1 Bernocchi Perry A · CIK 0001967402 · EVP, CEO,. Patient Direct 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 183,095 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| May 11, 2023 Filed May 12, 2023 13:05 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 6,583 | $18.39 | $121,061.37 |
DisclosureSEC source: 0001062993-23-010880 · form4.xml · nonDerivative · entry 1 Bernocchi Perry A · CIK 0001967402 · EVP, CEO,. Patient Direct 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 190,093 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 12:59 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 35,150 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-005695 · form4.xml · nonDerivative · entry 2 Bernocchi Perry A · CIK 0001967402 · EVP, CEO,. Patient Direct 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,676 F2 · security: Restricted stock which vests on March 15, 2024. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 12:59 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 64,767 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-005695 · form4.xml · nonDerivative · entry 1 Bernocchi Perry A · CIK 0001967402 · EVP, CEO,. Patient Direct 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,526 F1 · security: Restricted stock grant which vests one-third per year over three years. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.